A Practical Narrative Review on the Role of Magnesium in Cancer Therapy

Abstract

Magnesium (Mg²⁺) has gained oncologists' attention due to its wide range of biological functions and frequent use as a complementary or integrative agent. This review outlines Mg's actions, its complex role in carcinogenesis and tumor risk, and clinical issues. Mg²⁺ is essential in numerous biochemical processes, including adenosine triphosphate production, cellular signal transduction, DNA, RNA and protein synthesis, and bone formation. Pertinent full-text articles were thoroughly examined, and the most relevant ones were selected for inclusion in this review. There is conflicting scientific evidence about the relationship between Mg²⁺ changes and cancer risk, apart from colorectal cancer. Chronic Mg²⁺ deficiency leads to immune dysfunctions and enhanced baseline inflammation associated with oxidative stress related to various age-associated morbidities and cancer. On the other hand, Mg²⁺ deficiency is associated with drug or chemotherapy-related hypomagnesemia, postoperative pain, cachexia, opioid-induced constipation, normal tissue protection from radiation damage, and prevention of nephrotoxicity. A balanced diet usually provides sufficient Mg²⁺, but supplementation may be necessary in some clinical settings.

Keywords: cancer risk; carcinogenesis; drug interactions; hypomagnesemia; magnesium.

Figure 1

Interrelations between Mg⁺⁺ and various cancer settings.